公司概覽
業務類別 --
業務概覽 Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
公司地址 85 Wells Avenue, 2nd Floor, Newton, MA, USA, 02459
電話號碼 +1 617 658-0600
傳真號碼 --
公司網頁 https://www.karyopharm.com
員工數量 228
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Michael Mason, C.P.A.,M.B.A. Executive Vice President, Chief Financial Officer, Treasurer and Principal Accounting Officer 美元 500.32K 29/08/2024
Dr. Sharon Shacham, M.B.A.,PhD Chief Scientific Officer 美元 499.91K 01/03/2022
Mr. Ran Frenkel, R.Ph. Executive Vice President and Chief Development Officer 美元 429.53K 01/03/2022
Dr. Stephen Mitchener, Pharm.D. Senior Vice President and Chief Business Officer -- 17/02/2023
Mr. Richard Paulson, M.B.A. Director, President and Chief Executive Officer 美元 770.00K 13/04/2026
Dr. Reshma Rangwala, M.D.,PhD Executive Vice President and Chief Medical Officer 美元 567.74K 13/02/2026
Mr. Michael Mano, J.D. Executive Vice President, Chief Legal Officer and Secretary -- 13/02/2026
Ms. Lori Macomber, C.P.A. Executive Vice President, Chief Financial Officer and Treasurer -- 13/02/2026
Ms. Sohanya Roshan Cheng, M.B.A. Executive Vice President and Chief Commercial Officer -- 13/02/2026
Mr. Stuart Poulton Executive Vice President and Chief Development Officer 美元 500.14K 13/02/2026
Ms. Kristin Abate Vice President, Chief Accounting Officer, and Assistant Treasurer -- 13/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Barry E. Greene Lead Independent Director 13/04/2026
Mr. Chen Schor, M.B.A. Independent Director 13/04/2026
Mr. Garen G. Bohlin Independent Director 13/04/2026
Dr. Deepika Rachel Pakianathan Independent Director 13/04/2026
Dr. Peter K. Honig, M.D.,M.P.H. Independent Director 08/12/2023
Dr. Mansoor Raza Mirza, M.D. Independent Director 14/04/2025
Mr. Richard Paulson, M.B.A. Director, President and Chief Executive Officer 13/04/2026
Ms. Christy J. Oliger Independent Director 13/04/2026
Dr. Zhen Su Independent Director 13/04/2026
 
所屬ETF (更新日期: 12/11/2026 02:25)
代號 名稱 佔比% ▼ 持有日期
FLQSFranklin US Small Cap Mltfctr Idx ETF0.003%31/10/2026
AVUSAvantis® U.S. Equity ETF0.003%29/07/2023
RESMColumbia Research Enhanced Small Cap ETF0.0002%31/10/2026
HDGProShares Hedge Replication0.0001%30/10/2026
STXKStrive 2000 ETF0.0001%30/12/2022
RBProshares Russell 2000 Dynamic BufferETF0.00002%30/10/2026
AVUSAvantis US Equity ETF<0.000001%19/10/2023
BBPVirtus LifeSci Biotech Products ETF<0.000001%16/12/2021
BBSCJPMorgan BetaBuilders US Sml Cp Eq ETF<0.000001%20/12/2021
BIBProShares Ultra Nasdaq Biotechnology<0.000001%18/12/2023
BMEDBlackRock Future Health ETF<0.000001%05/05/2021
BMEZBlackRock Health Sciences Trust II<0.000001%30/06/2021
CNCRRange Cancer Therapeutics ETF<0.000001%01/04/2025
DFACDimensional US Core Equity 2 ETF<0.000001%27/04/2022
DFASDimensional US Small Cap ETF<0.000001%14/06/2023
ESMLiShares ESG Aware MSCI USA Small-Cap ETF<0.000001%27/05/2021
FADFirst Trust Multi Cap Gr AlphaDEX® ETF<0.000001%08/01/2021
FEACFidelity Enhanced U.S. All-Cap Eq ETF<0.000001%11/08/2026
FESMFidelity Enhanced Small Cap ETF<0.000001%21/02/2025
FHLCFidelity MSCI Health Care ETF<0.000001%06/09/2023
  1   2    3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.